Edition
ISBN:
0128197552 /
ISBN-13:
9780128197554
Book Details
Seller
Sort
Seller Rating
Price: Low to High
Price: High to Low
Condition
Condition: Reverse
Pub Date
Pub Date: Reverse
Sellers Near Me
Hardcover,
New
Immunotherapeutic Strategies for the Treatment of Glioma (Volume 3) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 3)
by Jackson, Christopher
2021, Elsevier Science
ISBN-13:
9780128197554
See Item Details ▾
Paperbackshop
HIGH
Bensenville,
IL,
USA
$155.62
$175.00
Add to Cart
Add this copy of Immunotherapeutic Strategies for the Treatment of to cart. $155.62, new condition, Sold by Paperbackshop rated 4.0 out of 5 stars, ships from Bensenville, IL, UNITED STATES, published 2021 by Elsevier Science.
Edition:
2021, Elsevier Science
Hardcover,
New
Available Copies: 3
Details:
ISBN:
0128197552
ISBN-13:
9780128197554
Publisher:
Elsevier Science
Published:
9/14/2021 12: 00: 00 AM
Language:
English
Alibris ID:
17973202724
Shipping Options:
Standard Shipping: $4.99
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New Book. Shipped from US in 4 to 14 days. Established seller since 2000. Please note we cannot offer an expedited shipping service from the US.
Hide Details ▴
Hardcover,
Good
Immunotherapeutic Strategies for the Treatment of Glioma (Volume 3) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 3)
2021, Academic Press
ISBN-13:
9780128197554
See Item Details ▾
Bonita
HIGH
Newport Coast,
CA,
USA
$182.83
Add to Cart
Add this copy of Immunotherapeutic Strategies for the Treatment of to cart. $182.83, good condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 2021 by Academic Press.
Edition:
2021, Academic Press
Hardcover,
Good
Details:
ISBN:
0128197552
ISBN-13:
9780128197554
Publisher:
Academic Press
Published:
2021
Language:
English
Alibris ID:
17961471039
Shipping Options:
Standard Shipping: $4.99
Trackable Expedited: $9.99
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Good. Access codes and supplements are not guaranteed with used items. May be an ex-library book.
Hide Details ▴
Hardcover,
New
Immunotherapeutic Strategies for the Treatment of Glioma (Volume 3) (Sensitizing Agents for Cancer Resistant to Cell Mediated Immunotherapy, Volume 3)
2021, Academic Press
ISBN-13:
9780128197554
See Item Details ▾
Revaluation Books
HIGH
Exeter,
DEVON,
UNITED KINGDOM
$197.41
Add to Cart
Add this copy of Immunotherapeutic Strategies for the Treatment of to cart. $197.41, new condition, Sold by Revaluation Books rated 4.0 out of 5 stars, ships from Exeter, DEVON, UNITED KINGDOM, published 2021 by Academic Press.
Edition:
2021, Academic Press
Hardcover,
New
Available Copies: 2
Details:
ISBN:
0128197552
ISBN-13:
9780128197554
Publisher:
Academic Press
Published:
2021
Language:
English
Alibris ID:
17599932536
Shipping Options:
Standard Shipping: $4.99
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. 250 pages. 9.25x7.75x0.50 inches.
Hide Details ▴
Hardcover,
New
Immunotherapeutic Strategies for the Treatment of Glioma
by Jackson, Christopher (Editor), and Lim, Michael (Editor)
2021, Academic Press
ISBN-13:
9780128197554
See Item Details ▾
Booksplease
HIGH
Southport,
MERSEYSIDE,
UNITED KINGDOM
$207.28
Add to Cart
Add this copy of Immunotherapeutic Strategies for the Treatment of to cart. $207.28, new condition, Sold by Booksplease rated 4.0 out of 5 stars, ships from Southport, MERSEYSIDE, UNITED KINGDOM, published 2021 by Academic Press.
Edition:
2021, Academic Press
Hardcover,
New
Available Copies: 5
Details:
ISBN:
0128197552
ISBN-13:
9780128197554
Publisher:
Academic Press
Published:
2021
Language:
English
Alibris ID:
17950663141
Shipping Options:
Standard Shipping: $4.99
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. Sewn binding. Cloth over boards. 190 p. Contains: Illustrations, color. Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy.
Hide Details ▴